Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
12.74
-0.37 (-2.82%)
At close: Sep 8, 2026, 4:00 PM EDT
12.99
+0.25 (1.96%)
After-hours: Sep 8, 2026, 7:44 PM EDT
Immunic Market Cap
Immunic has a market cap or net worth of $173.83 million as of September 8, 2026. Its market cap has increased by 131.55% in one year.
Market Cap
173.83M
Enterprise Value
19.30M
1-Year Change
131.55%
Ranking
Category
Stock Price
$12.74
ChartMarket Cap Chart
Since April 15, 2019, Immunic's market cap has decreased from $243.61M to $173.83M, a decrease of -28.64%. That is a compound annual growth rate of -4.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 173.83M | 170.78% |
| Dec 31, 2025 | 64.20M | -28.73% |
| Dec 31, 2024 | 90.08M | 33.02% |
| Dec 29, 2023 | 67.72M | 9.04% |
| Dec 30, 2022 | 62.10M | -75.28% |
| Dec 31, 2021 | 251.21M | -20.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 15, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Innate Pharma | 186.80M |
| Canton Strategic Holdings | 177.69M |
| MediWound | 173.51M |
| Spruce Biosciences | 169.83M |
| LENZ Therapeutics | 167.47M |
| Humacyte | 165.26M |
| Caribou Biosciences | 165.10M |
| Kazia Therapeutics | 164.58M |